ArticleBMC cancer2016

Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.

Johanna Samulin Erdem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.